Jamie Gavin has recently joined Societe Generale Prime Services as EMEA Head of OTC Clearing Sales (see Newedge below). Jamie has worked within financial services for 20 years. He worked at Goldman Sachs for 10 years where his roles included managing Listed Derivatives clearing, Foreign Exchange interbank and cross-product collateral management. More recently he worked at Morgan Stanley for 9 years, initially as European Head of OTC Collateral Management, then as European Head of Product Development for OTC Clearing and then finally Global Head of Listed and OTC Derivative Projects.
Jamie holds an Honours Degree in Computer Science and Management Studies from Royal Holloway, University of London.
Newedge, a world-leading derivatives broker, is 100% owned and controlled by Societe Generale. A brokerage specialist, our sole focus is to help clients succeed by delivering innovative, superior, multi-asset solutions, across a broad range of listed and OTC derivatives and securities. The Newedge vision is to always be a responsible leader in the world of brokerage, an industry where transparency and impartiality are as important as speed and efficiency. The Newedge Alternative Investment Solutions is an innovator in providing investors with benchmarking tools that accurately represent key hedge fund strategy styles. The Newedge family of indices represents a range of non-investable products that are highly relevant for demonstrating potential for diversification of returns.